Insider Transactions in Q4 2021 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
310,097
-13.52%
|
$189,159,170
$610.04 P/Share
|
|
Dec 22
2021
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
442,267
+16.15%
|
$99,067,808
$224.78 P/Share
|
|
Dec 16
2021
|
P Roy Vagelos Director |
SELL
Discretionary transaction
|
Indirect |
126
-2.86%
|
$79,884
$634.87 P/Share
|
|
Dec 13
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
344
-1.72%
|
$224,632
$653.12 P/Share
|
|
Dec 13
2021
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
116
-0.39%
|
$76,792
$662.5 P/Share
|
|
Dec 11
2021
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
697
-2.23%
|
$462,808
$664.34 P/Share
|
|
Dec 11
2021
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
388
-1.9%
|
$257,632
$664.34 P/Share
|
|
Dec 11
2021
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
697
-2.61%
|
$462,808
$664.34 P/Share
|
|
Dec 11
2021
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-1.4%
|
$499,992
$664.34 P/Share
|
|
Dec 11
2021
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
697
-1.18%
|
$462,808
$664.34 P/Share
|
|
Dec 11
2021
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-1.26%
|
$179,280
$664.34 P/Share
|
|
Dec 11
2021
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
697
-2.32%
|
$462,808
$664.34 P/Share
|
|
Dec 10
2021
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-4.4%
|
$918,976
$664.34 P/Share
|
|
Dec 10
2021
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.55%
|
$832,500
$555.67 P/Share
|
|
Dec 10
2021
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
781
-0.16%
|
$518,584
$664.66 P/Share
|
|
Dec 10
2021
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
7,122
-0.71%
|
$4,729,008
$664.97 P/Share
|
|
Dec 09
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,784
-64.55%
|
$2,516,360
$665.0 P/Share
|
|
Dec 09
2021
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,784
+39.23%
|
$1,403,864
$371.4 P/Share
|
|
Dec 09
2021
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
19,772
-42.5%
|
$12,990,204
$657.11 P/Share
|
|
Dec 09
2021
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+39.21%
|
$5,370,000
$179.13 P/Share
|
|
Dec 09
2021
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,469
-10.14%
|
$2,279,133
$657.11 P/Share
|
|
Dec 09
2021
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+11.05%
|
$1,695,750
$399.66 P/Share
|
|
Dec 09
2021
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
9,378
-12.39%
|
$6,161,346
$657.11 P/Share
|
|
Dec 09
2021
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+17.9%
|
$858,000
$52.03 P/Share
|
|
Dec 08
2021
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,859
+8.0%
|
-
|
|
Dec 08
2021
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Grant, award, or other acquisition
|
Direct |
3,338
+16.81%
|
-
|
|
Dec 08
2021
|
Marion Mc Court EVP Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
3,338
+14.08%
|
-
|
|
Dec 08
2021
|
Neil Stahl EVP Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
2,926
+5.15%
|
-
|
|
Dec 08
2021
|
P Roy Vagelos Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,861
+0.58%
|
-
|
|
Dec 08
2021
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Grant, award, or other acquisition
|
Direct |
4,344
+12.2%
|
-
|
|
Dec 08
2021
|
Robert E Landry EVP Finance CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,971
+11.7%
|
-
|
|
Dec 08
2021
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
3,462
+5.53%
|
-
|
|
Dec 03
2021
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
50,352
-49.7%
|
$31,822,464
$632.45 P/Share
|
|
Dec 03
2021
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
72,500
+41.71%
|
$12,977,500
$179.13 P/Share
|
|
Dec 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$639,000
$639.13 P/Share
|
|
Dec 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Dec 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$63,600
$636.48 P/Share
|
|
Nov 29
2021
|
Neil Stahl EVP Research and Development |
BUY
Bona fide gift
|
Indirect |
4,605
+50.0%
|
-
|
|
Nov 29
2021
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
4,605
-13.78%
|
-
|
|
Nov 22
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.19%
|
$1,314,000
$657.5 P/Share
|
|
Nov 19
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
1,000
-3.04%
|
$655,000
$655.0 P/Share
|
|
Nov 19
2021
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
359,137
-30.2%
|
$233,798,187
$651.96 P/Share
|
|
Nov 19
2021
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
520,313
+30.34%
|
$116,550,112
$224.78 P/Share
|
|
Nov 18
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
4,000
-10.85%
|
$2,600,000
$650.0 P/Share
|
|
Nov 17
2021
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
681
-2.55%
|
$439,245
$645.08 P/Share
|
|
Nov 16
2021
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
500
-2.17%
|
-
|
|
Nov 16
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
750
-42.86%
|
$487,500
$650.0 P/Share
|
|
Nov 16
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
6,000
-4.9%
|
$3,936,000
$656.26 P/Share
|
|
Nov 16
2021
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,069
-10.32%
|
$1,997,919
$651.97 P/Share
|
|
Nov 16
2021
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+11.2%
|
$1,496,250
$399.66 P/Share
|